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Abstract 
One of the leading causes of serious visual impairment in young children is 
congenital cataracts (1). Cataracts and subsequent reductions in vision are the result of 
opacification of the lens. The human lens is primarily made up of water-soluble proteins 
called crystallins, which are divided into three groups, alpha, beta, and gamma (2). 
Mutations in all three of the types have been found to cause the formation of cataracts, 
although the exact mechanisms remain elusive (3). An autosomal dominant mutation in 
human alphaA crystallin was discovered to be the cause of one type of congenital cataract 
in humans (3). In order to study the mechanism by which this mutation results in cataract 
formation it is necessary to first study the normal form of human alphaA crystallin. This 
project accomplishes the expression, isolation, and purification of human alphaA 
crystallin. 
Introduction 
The human lens is a unique and complex organ. Its primary function is to 
eliminate retinal blur. The strict control of lens transparency is required to achieve this 
goal (4). Proper nutrient metabolism as well as regular folding of the lens crystallins, 
which make up 90% of the lens proteins, are essential to maintaining transparency (2,5). 
There are three classes of crystallins in the lens, alpha, beta, and gamma, which interact 
and pack together in a complex manner so that light can pass through the lens with 
minimum scattering. Any disruption in the ordered packing of the crystallin proteins 
would lead to cataracts. The exact three dimensional structures of all the crystallins are 
not yet known, but based on their secondary structures, they are thought to be made up 
mainly of beta sheet and alpha helical subunits, which ultimately influence their folding 
tendencies into three dimensional structures (2,6). The purpose of this project is to 
express and purify human alphaA crystallin so that it can be further studied. 
Alpha crystallin is the largest of the three crystallins, based on molecular weight 
(2), and comprises 40-50% of total lens proteins (5,7). There are two main subtypes of 
alpha crystallin, alphaA and alphaB (2). Although their N-terminal regions differ, 
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alphaA and alphaB share a 57% C-terminal sequence homology. Therefore, despite some 
similarities, these proteins differ in their relative functions (5,7,8). AlphaB appears to be 
produced in response to stress in many non-ocular tissues in the body (8,9). AlphaA, on 
the other hand, appears to play a major structural role in the lens, and is not found to be 
abundant in any other human tissue (8). Approximately 32 subunits of alphaA and 
alphaB come together via hydrophobic interactions to form a multimer of approximately 
800kDa (6,8,10). In part, this considerable size and complexity has limited the study of 
alpha crystallin's structure (8,9). 
A conserved region of 100 amino acids in both alphaA and alphaB crystallin 
make them distant relatives of a functionally related group of proteins called heat shock 
proteins (HSP's) (9,11). However, strong evidence suggests that alphaA is the more 
stable of the two alpha crystallins (7). HSP's have been studied in a number of different 
organisms, and although their structures may be vastly different, their universal function 
appears to be to aide in proper protein folding and breakdown, and to maintain the correct 
conformations of proteins during times of stress (11). 
The proteins in the lens are formed during fetal development and do not continue 
to replicate throughout life. In this static environment, where there is a lack of protein 
turnover, repair and maintenance mechanisms are of paramount importance (5). A 
protein that assists in the folding of other proteins, is called a molecular chaperone (11). 
In the lens, alphaA is believed to demonstrate molecular chaperone-like activity (5,7,11). 
Ensuring the correct folding of the other crystalhns and protecting them from incorrect 
aggregations is essential to maintaining proper lens transparency (11). By recognizing 
unfolded or partially denatured regions, and sequestering them, alphaA crystallin may be 
the vital link in understanding cataract formation. 
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By studying the normal aging process of the lens, which results in cataracts, it has 
been shown that the crystallins become more insoluble over time (2). High molecular 
weight aggregates of the crystallins begin to appear and increase in size with age (2). 
Breakdown in the proper folding of the crystallins and the formation of disulfide bridges 
between proteins may account for the formation of these aggregates (2). The role of 
alphaA crystallin appears to be to prevent these processes from occurring and therefore 
plays a vital role in preventing or slowing cataract formation (8). 
Mutations in the genes of all three types of crystallins have been found to cause 
cataracts (3,10,12). Of particular interest to this project was the discovery of an 
autosomal dominant congenital cataract (ADCC) due to a mis-sense mutation in the 
human alpha crystallin gene (CRYAA), by Litt et al. Litt et al studied a particular family, 
in which 13 individuals, over 4 generations, were afflicted with congenital cataracts. 
Genetic testing showed that the same mis-sense mutation on chromosome 21 existed in 
all afflicted family members while other family members lacked the mutation (3). The 
single base pair change in the DNA sequence of the alpha crystallin gene results in an 
amino acid arginine(R116) being converted to a cysteine(C116) residue (3). 
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Although this small change may appear moderately harmless on the surface, each 
of these two amino acids have significantly different properties, when considered in 
terms of their effects on secondary structure of a protein. As was previously mentioned, 
the crystallins are primarily made up of alpha helices and beta sheets. Although any of 
the 20 amino acids can be incorporated into alpha helices and beta sheets, certain ones are 
more stable and sterically suitable for these structures than others (10). Cysteine is a key 
player in the formation of disulfide bridges, and is therefore capable of disrupting alpha 
helix and beta sheet formations (10). Disulfide bridges play a role in proper protein 
folding and any changes in the formation of these bridges can have profound effects on 
the final structure. 
In order to determine if alphaA crystallin's structure is being altered by the mis-
sense mutation, one must first study the normal form of alphaA crystallin. Little is 
known about the exact three-dimensional structure of alphaA crystallin at this time. 
Many theoretical models have been proposed, mainly spherical or globular in nature, and 
are largely based on its secondary structure (6,11). By determining the exact folding 
nature of both normal alphaA and the mutated form of alphaA, it may be possible to 
determine how the mutation leads to cataract formation. Three-dimensional studies of 
the two forms of alphaA, including nuclear magnetic resonance (NMR) and electron spin 
resonance (ESR) may ultimately be employed to detennine the differences between the 
two similar proteins. This project focuses on the expression and purification of 
normal human alphaA crystallin. 
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Materials and Methods 
Figure 1 
Flowchart of Events with pCAL Coning System 
Step One: Conversion of RNA into eDNA 
+ 
Step Two: Ligation of alphaA eDNA into E. coli Cloning Vector 
• Step Three: Confirmation of Cloning reaction by separation on SDS-PAGE 
• Step Four: Ligation of alphaA eDNA into E. coli Expression Vector 
• Step Five: Induction of Protein Expression 
• Step Six: Separation of alphaA Protein from other E. coli Proteins 
• Step Seven: Confirmation of Presence of alphaA Protein by Immunoreactivity 
• Step Eight: Purification of alphaA Protein with Calmodu1in Resin 
• Step Nine: Cleavage of Calmodulin Binding Protein Tag 
Step One 
Total human RNA was previously extracted from donor lenses (13). A eDNA 
copy of the genetic material was produced via reverse transcriptase-polymerase chain 
reaction (RT-PCR) and gene specific primers. Once the eDNA of alphaA was obtained, 
primers were designed specifically to allow ligation into the pCAL-N-EK expression 
vector shown in Figure 2 (Stratagene Cloning Systems, La Jolla, CA) 
Figure 2 
17/acO 
pi'IOmoter pCAL·n-EK 
vector 
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T7 terminator 
The pCAL vector was chosen in part because it contains a Calmodulin binding 
peptide (CBP) tag. This allows alphaA DNA to be inserted as the "fusion protein" in the 
diagram. Once alphaA is ligated into the vector, it allows for easy purification with a 
Calmodulin affinity resin. Also contained in the pCAL vector is a recognition site for a 
site-specific protease enterokinase (EK), located between the CBP tag and the alphaA 
insert. This protease (EK) can later be used to cleave the CBP tag, leaving only the 
alphaA protein. The T7 promotor is highly effective, allowing efficient multiplication of 
the vector and alphaA insert. 
Primers were specifically designed to allow ligation to a specific section of 
alphaA DNA. Primers must be able to anneal to the alphaA DNA, and also to separate 
from the alphaA DNA during the different phases of the PCR reaction. Once the gene 
specific primers were designed, lf..Ll of alphaA eDNA was amplified by PCR. Standard 
PCR protocol was performed in a thermal cycle machine, using 2.5 units of Tag 
Polymerase. The PCR products were then resolved on a 1% agarose gel and stained with 
Ethidium Bromide. The bands were excised from the gel and weighed. The amplified 
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DNA was then purified from the agarose gel and an optic density (OD) reading was taken 
to determine the concentration of DNA. (An OD reading equal to 1 at 260nm equals 
50~g/rnL microgram of double stranded DNA.) The alphaA DNA was then ligated with 
l~L of pCAL vector and incubated at room temperature for four hours. 
Step Two 
Transfmmation of the ligation product into the XLl-Blu strain of E. coli cells 
was performed. As the XLl-Blu strain of E. coli lacks the T7 promoter region necessary 
for protein expression, it was specifically used to amplify the alphaA DNA insert, while 
keeping protein expression to a minimum. The ligation vector product was incubated 
with the XLl-Blu cells in culture broth (SOC medium) at 37°C for one hour on a shaker. 
Several aliquots of the transformation reaction mixture were plated onto agar plates 
containing Ampicillin, to prevent contaminating bacteria growth. The plates were 
inverted and incubated at 3rc overnight. 
Step Three 
Several colonies of cells were picked from the agar plates described above and 
allowed to amplify in culture broth overnight at 37°C. Culture broths of E. coli were 
spun down and cells were lyzed with strong detergents. The plasrnids from the lysed 
cells were isolated. These plasmid preparations were screened for the presence of the 
alphaA insert using gene specific primers to alphaA in a PCR reaction. The PCR 
products were visualized on a 1.5% agarose gel. 
Step Four 
Positive colonies were transformed into BL21(DE3)pLysS cells. These DE3 cells 
are another strain of E. coli cells. The DE3 cells contain the T7 promoter region and are 
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therefore used for protein expression of the alphaA insert. By varying the growth 
conditions of the DE3 cells using IPTG, overexpression of the alphaA protein is possible. 
Once again, the transformation reaction mixtures were plated onto agar, containing 
Ampicillin, and were incubated overnight at 37°C. 
Several colonies were picked and the transformed DE3 cells were cultured 
separately in Luria culture broth (LB broth) containing Ampicillin, Chloramphenicol, and 
Glucose for three hours, with continuous shaking at 37°C. In order to monitor the growth 
of the cells, an OD reading at 600nm was periodically taken. 
Step Five 
Once an adequate concentration of cells was acquired, half the cells were stored 
undisturbed at 4 oc as a control. To the other half of the cells, Isopropyl-beta-D-
thiogalactopyranoside (IPTG) was added to induce protein expression. The induced cells 
were shaken at 37°C for two hours. A small portion of cells were then centrifuged down 
into pellets and stored in a 30% glycerol stock at -80°C to allow cells to be amplified in 
the future as needed. 
Step Six 
To determine levels of protein induction, E. coli proteins from the celllysates 
were first separated from alphaA protein on a sodium dodecyl sulfate-polyacrylamide gel 
(SDS-PAGE). Protein concentration of the cell lysate was determined by a modified 
biuret method according to manufacturers instructions (BCA Protein Assay, PIERCE, 
Rockford, II). The protein samples were diluted to approximately the same concentration 
and were separated on an SDS-PAGE gel. The gel was stained with Coomassie Blue to 
visualize the bands of the expressed proteins. 
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Step Seven 
To confirm that the desired protein had been expressed, an immunoblot was 
performed using a specific anti-alpha crystallin antibody. Proteins separated on the SDS-
PAGE gel were transferred to blotting paper, polyvinylidene difluoride (PVDF), by 
electrophoresis using NOVEX mini-apparatus according to manufacturers protocol 
(NOVEX Experimental Technology, San Diego, CA). Following incubation with the 
primary anti-alpha antibody, positive immunoreactivity was detected by incubating with 
secondary goat-antirabbit IgG antibody, conjugated to alkaline phosphatase. An 
immunoreactive band was visualized by color development upon cleavage of alkaline 
phosphatase substrate. 
Step Eight 
After confirmation of alphaA expression, the expressed protein was purified. The 
alphaA protein was cleaved from the Calmodulin binding protein of the pCAL vector. 
After induction and pelleting of the cells, they were lysed with a mixture ofLysosyme, 
Pepstatin A, dithiothreitol (DTT), and phenylmethanesulfonyl fluoride (PMSF). The 
cells were centrifuged to separate the soluble proteins, the supernatant, from the cell 
remnant pellet. The supernatants were incubated with a Calmodulin binding resin 
column for three hours. This resin binds to the tag on the expressed protein. The resin 
was spun down to separate the resin from the binding buffer containing unwanted E. coli 
proteins. A portion of the supernatant buffer was removed from the resin in preparation 
for visualization on an SDS-PAGE gel. The resin was washed several times with binding 
buffer and portions from these washes were also prepared for a gel. A buffer containing 
EGT A was used to elute alphaA. Samples of these elutions along with the washes, 
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supernatant buffer, and a sample of unbound alphaA were all visualized on a SDS-PAGE 
gel. After purification of the protein, an attempt was made to cleave off the CBP tag. 
Step Nine 
The elutions from the column were first equilibrated with an Enterokinase (EK) 
cleavage buffer and were incubated with EK protease overnight at 3rC. The results of 
the cleavage reaction were subsequently separated on an SDS-PAGE gel. 
After several unsuccessful attempts at cleaving the CBP, it was decided to try a 
second expression kit that did not include a binding tag. It was believed that the alphaA 
crystalline remained bound to the resin and therefore an alternate method was required to 
purify the protein. Subsequently the pCR-T7/CT TOPO-TA expression kit was chosen 
(Invitrogen Corporation, Carlsbad, CA). Although this kit would make purification of 
the expressed protein more difficult, due to the lack of a binding tag, it was felt that it was 
a necessary step in order to get purified native alphaA protein. 
Alternate Cloning Method 
Methods to express protein using the TOPO kit parallel those procedures 
described above with the pCAL kit, with the notable exception of the tag. Briefly, the 
TOPO kit method is described below. 
Ligation into TOPO Cloning Vector 
The alphaA DNA was ligated into the T7/CT TOPO vector. The ligated vector 
was then transformed into Top lOP' cells. These cells were amplified and the alphaA 
ligated insert was purified using a minispin kit according to manufacturer's protocol 
(Qiagen Inc., Valencia, CA). 
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Transformation into Expression Cells and Protein Induction 
Plasmids containing alphaA were transformed into DE3 expression cells and 
incubated at 37°C to culture several liters of cells. Protein expression was induced with 
IPTG and allowed to incubate. The DE3 cells were lysed and the supernatants containing 
the soluble proteins were separated onto an SDS-PAGE gel. 
Immunoreactivity and Sequence Confirmation 
Immunoblotting was performed to detect alphaA. The alphaA protein was 
purified using anion-exchange and gel filtration chromatography. DNA sequencing 
further confirmed the presence of alphaA insert and agreed with the published sequence 
(GenBank Accession No. U05569). 
Results 
Transcription and PCR Reactions (pCAL kit) 
AlphaA crystallin was cloned and expressed. The following figures outline the 
results at each step within the process. The first step in cloning alphaA was the PCR 
transc1iption of the gene as shown in Figure 3. Using the gene specific primers, alphaA 
eDNA was transcribed from donor RNA and amplified via PCR. The PCR reactions 
were visualized on agarose gels (lane 2, 3, and 4) with known molecular weight 
calibrating basepair (bp) standards (lane 1 ). 
Figure 3 
600bp 
Marker 
Lanes 1 2 3 4 
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The lack of bands in lane 4 in Figure 3, indicates a colony in which cloning was not 
successful. Heavy bands of approximately 600bp when compared to standards, are 
evident in lanes 2 and 3 in Figure 3, and correspond to the size of the alphaA eDNA plus 
the CBP tag. This indicates the presence of alphaA eDNA and confirms that the 
transcription and PCR reactions were successful. 
Ligation and Transformation 
After amplification, the alphaA eDNA was ligated into the pCAL vector and 
cultured in a strain of E. coli cells. Following isolation of the plasmids from selected 
colonies, a PCR screen was performed (Figure 4) to confirm ligation and aliquots were 
separated on an agarose gel (lanes 1,2,3). 
Figure 4 Lanes 1 2 3 4 
600bp 
Marker 
When compared to molecular weight standards in lane 4, Figure 4 shows a heavily 
stained band in lane 1 corresponding to 600bp. This confitms the presence of alphaA 
insert with the CBP tag in the plasmid from one of the picked colonies of XL1-Blu cells. 
Lanes 2 and 3 are from colonies in which no ligation occurred. Thus, the band in lane 1 
demonstrates that ligation and transformation of the cloning cells was successful. 
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Induction and Expression 
After completion of cloning, the alphaA protein was expressed. The protein 
product of alphaA crystallin was expressed via transformation and induction of DE3 
expression cells with IPTG. Lysed portions of DE3 cells were run through a Calmodulin 
resin column in order to separate the alphaA protein from all the other cell proteins. Each 
pair of lanes, (1-2, 3-4, 5-6) in Figure 5, corresponds to the non-induced control and 
induced portions of DE3 cell colonies respectively. The elutions of these different cell 
lines were separated on an SDS-PAGE gel to visualize the expressed alphaA product 
(Figure 5). The heavily stained bands in lanes 2, 4, and 6 of Figure 5 approximately 
correspond to 25 kDa, when compared with the molecular weight markers in lanes 1 and 
7. This is in agreement with the expected molecular weight of the alphaA protein with 
the CBP tag attached. Figure 5 clearly shows that protein was induced in at least 3 
different colonies of DE3 cells. The presence of alphaA protein was definitively 
confirmed by detection with an anti-alpha antibody, as shown in Figure 6. The 
immunoblot showed an intensely stained band at 27kDa, just above the 25kDa marker 
(Figure 6). 
Figure 5 
Lanes 1 2 3 4 5 6 7 
Figure 6 
Lanes 1 
25kDa 
Marker 
2 
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This is where alphaA crystallin is expected to resolve by SDS-PAGE. No other proteins 
were detected in the immunoblot (lane 2), indicating specific immunoreactivity of the 
induced alphaA protein. 
Purification and Removal of Tag 
In order to separate the alphaA protein from the CBP, a cleavage reaction with 
Enterokinase was performed. The products of these reactions were resolved on a gel in 
Figure 7 (lanes 2 through 6) to confirm cleavage. 
Figure 7 Lanes 1 2 3 4 5 6 7 
25kDa 
Marker 
The lack of bands in lanes 2 through 6 in Figure 7 indicates an absence of the alphaA 
protein. The tagged alphaA remained bound to the column which resulted in the absence 
of protein in the elutions. Therefore, when the column was regenerated, the bound 
protein was discarded. Further attempts to cleave alphaA from the binding protein were 
made by varying the reaction conditions with similar negative results. This was 
surprising since the tag had been successfully cleaved off of a beta crystallin in a 
similarly designed study (14 ). 
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Cloning with TOPO Kit 
In order to express protein without a tag, a second system was employed. With 
the TOPO kit, alphaA eDNA was amplified using gene specific primers. The correct size 
of the eDNA was checked by separating the products on an agarose gel (figure 8). The 
alphaA was then ligated into ToplOF' cells which were cultured at 37°C. 
Figure 8 Lanes 1 2 3 4 5 
600bp 
Marker 
Bands in lanes 2, 3, and 4 of Figure 8 are consistent with the approximate length 
(600bp) for alphaA eDNA, when compared to the standard markers. After 
transformation and expression of alphaA protein in the TOPO system, the proteins were 
purified by anion exchange and gel filtration chromatography. The elutions from these 
columns were separated on an SDS-PAGE gel (Figure 9). The heavy bands in lanes 3 
(anion exchange) and 4 (gel filtration) correspond to the correct size of the alphaA 
crystallin protein. The other bands in lanes 3 and 4 are proteins, which were eluted from 
the chromatography column. However, they do not correspond to the correct molecular 
weight for alphaA crystallin. Lanes 1 and 2 of Figure 9 correspond to molecular weight 
markers and E. coli cell lysate respectively. 
Figure 9 
22kDa 
Marker 
Lanes 1 2 3 4 
Figure 10 
22kDa 
Marker 
Lanes 1 2 
The results of an Immunoblot, performed to confirm the presence of alphaA via 
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gel filtration chromatography, are shown in Figure 10. The heavily stained band in lane 1 
of Figure 10 shows the correct molecular weight of alphaA (without the CBP tag) and 
confirms the presence of alphaA protein. In order to ultimately complete this project and 
confinn the presence of alphaA protein, a sample of alphaA DNA was sent to the Core 
labs at OHSU for sequencing. The experimental sequence used for this project agreed 
with the published sequence for alphaA crystallin (GenBank Accession No. U05569). 
Thus, alphaA crystallin was successfully purified with the TOPO system. 
Discussion 
AlphaA crystallin was successfully cloned and expressed by two separate systems 
based on the following three lines of evidence. Initially, a positive PCR screening was 
obtained for both kits. Secondly, resolution of expressed protein on SDS-PAGE was 
achieved with both systems. Finally, immunoreactivity with a specific alphaA antibody 
was visualized with the two separate systems. 
The pCAL and TOPO systems require somewhat different protocols to achieve 
the same results. While the pCAL kit employs a built in purification step with its CBP, 
the TOPO kit requires a much less predictable method of purification. The TOPO kit 
requires the use of chromatography to isolate alphaA from the ligated vector in which it 
is amplified. 
The use of the pCAL kit, although it did not yield the desired outcome, did 
stimulate some interesting questions. Most importantly, why the enterokinase cleavage 
step failed? As the same kit was used in a simultaneous project with another crystallin 
with excellent results, it demonstrated that the pCAL kit does in fact work (14). The 
reason it failed with alphaA crystallin must lie in the nature of alphaA crystallin itself. 
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From more recent theories, it is suggested that the N-terminus of alphaA crystallin 
is buried and would not have been available for cleavage by the EK enzyme (6). TheN-
terminus may be buried within a single monomer of alphaA or it may be buried within 
the larger multimer of alphaA. Furthermore, the C-terminus and not theN-terminus has 
been shown to be available for modification during the aging process (15). Therefore, the 
logical reason for the lack of cleavage by the enterokinase with the pCAL system is that 
theN-terminal tag was buried and unavailable to the enzyme. 
The TOPO kit however, allowed the expression and purification of alphaA 
crystallin to be successfully completed. The lack of a binding tag eliminated the need for 
availability of theN-terminus of alphaA and, as such, the problem encountered with the 
pCAL kit disappeared. While additional purification steps were required, the alphaA 
protein obtained was approximately 90% pure (14). 
With alphaA crystallin available in soluble form, it may now be possible to study 
its three-dimensional structure via NMR and ESR techniques. The mutated form of 
alphaA crystallin, discovered by Litt et al, has also been created via site-directed 
mutagenesis (14). An initial agarose gel of the PCR cloning step of the mutated form of 
alphaA is shown in Figure 11 (14). In addition, primers have been designed for the 
mutated form of alphaA-crystallin to enable future projects (14). 
Figure 11 
Mutant wphaA 
eDNA 
Lanes 1 2 3 4 5 6 7 8 
The further expression and purification of mutated alphaA will allow the two 
types of alphaA to be comparatively studied. With these new achievements, it will be 
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possible to compare the two forms of human alphaA crystallin in their native forms. The 
remaining goals of studying the alteration of the three-dimensional configuration and 
determining and its role in the formation of congenital cataracts may prove invaluable to 
the future treatment and prevention of needless vision loss. 
Conclusions 
The expression and purification of alphaA crystallin is an important step in 
studying its role in cataract formation. Determining the biochemical nature of alphaA 
crystallin may elucidate the mechanisms by which cataracts develops. 
The goal of expressing alphaA crystallin has allowed many interesting facts about 
alphaA crystallin to be uncovered. The invaluable information learned about the N-
terminal region of alphaA crystallin will allow future studies to be better designed. 
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AlphaA crystallin needs to be studied in greater detail to uncover the role it plays 
in the formation of cataract in both the young and old. The ultimate goal of prevention of 
the devastating point mutation in alphaA crystallin may also be achieved. Only with 
continued research of all the types of crystallins will the mechanisms of cataract 
formation be elicited and possible solutions be hypothesized. 
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Glossary Terms Derived From the Following Sources: 
Harcourt Academic Press Dictionary of Science and Technology. 
http :I /www .harcourt.cornldictionary 
Sigma-Aldrich Co. 
Product Search 
http :I /www .sigma-aid rich.co rn!sa ws.nsf/analytical ?OpenFrameset 
Appendix A 
Glossary 
Materials Used 
eDNA- Complementary DNA synthesized by RNA-directed DNA polymerase using 
RNA as a template. 
CBP - Calmodulin Binding Protein Tag 
DIT - Dithiothreitol 
EGTA- Ethyleneglycol-bis-(beta-amino-ethyl ether)-N,N,N' ,N' -tetraacetic acid 
EK - Enterokinase enzyme 
Ethidium Bromide- A form of dye that prevents transcription and DNA replication by 
binding to specific regions of the DNA molecule. 
IPTG- Isopropyl-beta-D-thiogalactopyranoside 
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LB- Luria broth- Combination of NaCI, Tryptone, yeast extract, deionized water at a pH 
of7.0 
PVDF- Polyvinylidene Difluoride- filter membrane 
PMSF- Phenylmethanesulfonyl Fluoride 
RNA- A linear, usually single-stranded polymer of ribonucleotides. RNA encodes the 
information needed to synthesize proteins. 
SDS-PAGE -Sodium Dodecyl Sulfate- PolyAcrylamide Gel Electrophoresis 
SOC- Culture media containing of NaCl, Tryptone, yeast extract, MgC]z, MgS04, and 
filter sterilized 2M glucose solution 
Protein Chemistry Definitions 
Alpha helix- A secondary structure that occurs in many proteins; a right-handed helix 
with 3.6 amino acid residues per tum stabilized by hydrogen bonds. 
Beta sheet - A secondary structure, occuning in many proteins, resulting from the regular 
folding of polypeptide chains. 
C-terminus - The carboxyl end of a polypeptide chain of a protein molecule. 
N-terminus- The amino end of a polypeptide chain of a protein molecule. 
Ligation -The joining of two DNA strands by the formation of a phosphodiester bond 
between their terminal nucleotides. 
Mis-sense mutation- A mutation in which a codon (3 nucleotides in sequence) 
undergoes a nucleotide change such that it codes for a different amino acid, often 
resulting in the production of a nonfunctional protein. 
Monomer- A single polypeptide chain, that is able to combine with other like or unlike 
molecules to form larger polypeptide complexes. 
Multimer- A protein molecule composed of more than one polypeptide chain. 
Plasmid- A small, closed entity of double-stranded DNA forming an extrachromosomal 
self-replicating genetic element in many bacteria and some eukaryotes, often 
carrying genetic sequences that give the host cell a survival advantage such as 
resistance to antibiotics. 
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Point mutation - A mutation consisting of an alteration in a single nucleotide of a nucleic 
acid strand. 
Primer- A short single-stranded DNA fragment that is required to initiate polymerization 
of new DNA nucleotides. 
Promoter- A nucleotide sequence on a DNA strand that will initiate transcription. 
Protease- Any enzyme that catalyzes the hydrolysis of a protein into smaller substance 
parts. 
Secondary Structure- A protein structure; folding, twisting, coiled, often springlike chain 
resulting when hydrogen bonds form between the adjacent parts of a molecule, as 
in an alpha helix or beta sheet. 
Vector (Cloning)- A plasmid used in recombinant DNA experiments as an acceptor of 
foreign DNA. 
Vector (Expression)- A cloning vehicle designed to allow and promote the expression of 
an inserted gene. 
Techniques 
Anion Exchange Chromatography - A process in which anions in solution exchange with 
anions in an insoluble matrix or resin. 
Chromatography -A technique for separating components from a mixture by placing the 
mixture in a mobile phase that is passed over a stationary phase. 
ESR -Electron Spin Resonance 
Gel Filtration Chromatography- A separation technique based on molecular size in 
which the mobile phase is a liquid and the stationary phase consists of three-
dimensional networks of cross-linked polymer chains, such as beads of porous 
polymeric material 
NMR - Nuclear Magnetic Resonance 
PCR- Po~merase Chain Reaction- A process for amplifying a DNA molecule by up to 
10 to 109 fold; extremely important in biotechnology and in research. 
DNA Annealing- the renaturation of complementary single-stranded DNA molecules 
into double-stranded DNA following their earlier denaturation; involves the 
formation of hydrogen bonds between pairs of bases. 
